Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Share Price

Price 192.50p on 28-10-2025 at 06:00:04
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Last Trade: Sell 2,690.00 at 186.25p
Day's Volume: 0
Last Close: 192.50p
Open: 0.00p
ISIN: FI4000153309
Day's Range 0.00p - 0.00p
52wk Range: 142.50p - 265.00p
Market Capitalisation: £216.53m
VWAP: 0.00p
Shares in Issue: 112.48m

Faron Pharmaceuticals (FARN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 2,690 186.25p Ordinary
14:50:58 - 27-Oct-25
Buy* 500 197.00p Ordinary
14:03:25 - 27-Oct-25
Sell* 371 185.00p SI Trade
12:29:33 - 27-Oct-25
Buy* 113 192.00p Ordinary
08:12:48 - 27-Oct-25
Unknown* 5 195.00p SI Trade
08:10:10 - 27-Oct-25
Sell* 1,064 187.40p Ordinary
08:00:54 - 27-Oct-25
Sell* 25,000 185.00p Uncrossing Trade
16:35:20 - 24-Oct-25
Unknown* 85,094 184.72p Ordinary
16:31:55 - 24-Oct-25
Sell* 5,472 186.20p Ordinary
16:29:27 - 24-Oct-25
Buy* 15 195.00p SI Trade
16:21:04 - 24-Oct-25
See more Faron Pharmaceuticals trades

Faron Pharmaceuticals (FARN) Share Price History

Time period:
to
Date Open High Low Close Volume
28th Oct 2025 (Tue) 192.50 192.50 192.50 192.50 0
27th Oct 2025 (Mon) 187.50 192.50 187.50 192.50 5,188
24th Oct 2025 (Fri) 175.00 185.00 177.50 185.00 145,938
23rd Oct 2025 (Thu) 175.00 178.00 175.00 175.00 280,802
22nd Oct 2025 (Wed) 175.00 177.50 175.00 175.00 101,602
21st Oct 2025 (Tue) 182.50 175.00 175.00 175.00 53,678
20th Oct 2025 (Mon) 182.50 182.50 180.00 182.50 108,056
17th Oct 2025 (Fri) 177.50 180.00 175.00 180.00 74,056
16th Oct 2025 (Thu) 175.00 177.50 175.00 177.50 138,261
15th Oct 2025 (Wed) 175.00 175.00 175.00 175.00 67,693
14th Oct 2025 (Tue) 177.50 177.50 177.50 177.50 12,105
13th Oct 2025 (Mon) 177.50 177.50 160.00 177.50 63,336
10th Oct 2025 (Fri) 175.00 177.50 175.00 177.50 84,235
9th Oct 2025 (Thu) 175.00 175.00 175.00 175.00 25,999
8th Oct 2025 (Wed) 175.00 180.00 175.00 175.00 97,890
7th Oct 2025 (Tue) 180.00 175.00 175.00 175.00 71,148
6th Oct 2025 (Mon) 182.50 175.00 175.00 175.00 69,365
3rd Oct 2025 (Fri) 185.00 185.00 180.00 182.50 7,506
2nd Oct 2025 (Thu) 180.00 185.00 180.00 185.00 22,638
1st Oct 2025 (Wed) 180.00 180.00 175.00 180.00 253,619
30th Sep 2025 (Tue) 180.00 180.00 175.00 180.00 74,495
29th Sep 2025 (Mon) 185.00 175.00 175.00 175.00 198,682
See more Faron Pharmaceuticals price history

Faron Pharmaceuticals (FARN) Regulatory News

Date Source Headline
3rd Mar 2025 12:05 pm RNS FDA Grants Orphan Drug Designation
28th Feb 2025 12:00 pm RNS Notice of Annual General Meeting
27th Feb 2025 7:30 am RNS Positive EMA Opinion on Orphan Drug Designation
27th Feb 2025 7:15 am RNS Annual Report 2024 published
27th Feb 2025 7:00 am RNS Financial Statement 1 January to 31 December 2024
19th Feb 2025 10:00 am RNS Notice of Financial Statement and Annual Report
14th Feb 2025 12:00 pm RNS Holding(s) in Company
11th Feb 2025 7:30 am RNS Change of Broker
6th Feb 2025 3:00 pm RNS Holding(s) in Company
6th Feb 2025 7:00 am RNS Results of Oversubscribed Placing
See more Faron Pharmaceuticals regulatory news

Faron Pharmaceuticals (FARN) Share News

Faron says new data reinforces promise of bone marrow cancer drug

20th Oct 2025 13:34

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said updated biomarker data strengthened the clinical profile of bexmarilimab, its lead treatment for myelodysplastic syndrome. Read More

Faron Pharmaceuticals narrows loss as cancer treatment trials continue

27th Aug 2025 10:25

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday posted an improvement in half-year results with "strong and steady progress" for its immunotherapy programme. Read More

UK earnings, trading statements calendar - next 7 days

20th Aug 2025 12:20

Read More

Faron advances development of cancer immunotherapy after FDA feedback

18th Aug 2025 09:10

(Alliance News) - Faron Pharmaceuticals Ltd on Monday outlined its plans to further progress its study of an investigational cancer immunotherapy, after receiving positive and "valuable" feedback from the US Food & Drug Administration. Read More

LONDON MARKET OPEN: Stocks up with eyes on Powell at Jackson Hole

18th Aug 2025 08:54

(Alliance News) - Stock prices in London opened higher on Monday, as investors digest last week's meeting between Donald Trump and Vladimir Putin, and look to the Jackson Hole symposium and key data releases later in the week. Read More

See more Faron Pharmaceuticals news
FTSE 100 Latest
Value9,653.82
Change0.00

Login to your account

Forgot Password?

Not Registered